Gritstone Oncology Inc (GRTS)vsRevolution Medicines Inc (RVMD)
GRTS
Gritstone Oncology Inc
$0.03
0.00%
HEALTHCARE · Cap: $3.80M
RVMD
Revolution Medicines Inc
$155.69
+3.11%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Gritstone Oncology Inc generates 1869% more annual revenue ($14.61M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. GRTS earns a higher WallStSmart Score of 34/100 (F).
GRTS
Avoid34
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : GRTS
The strongest argument for GRTS centers on Price/Book.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : GRTS
The primary concerns for GRTS are EPS Growth, Market Cap, Profit Margin. Debt-to-equity of 4.62 is elevated, increasing financial risk.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
GRTS is growing revenue faster at -52.9% — sustainability is the question.
GRTS generates stronger free cash flow (-27M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
GRTS scores higher overall (34/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Gritstone Oncology Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Gritstone bio, Inc., a clinical-stage biotechnology company, is dedicated to developing tumor-specific cancer immunotherapies to combat various types of cancer and infectious diseases. The company is headquartered in Emeryville, California.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?